2012-10-10 21:32:00 - New Pharmaceuticals research report from Global Markets Direct is now available from Fast Market Research

Global Market Direct's pharmaceuticals report, "AiCuris GmbH & Co. KG - Product Pipeline Review - 2012" provides data on the AiCuris GmbH & Co. KG's research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct's proprietary databases, AiCuris GmbH & Co. KG's corporate website, SEC filings, investor presentations and featured press releases, both from AiCuris GmbH & Co. KG and industry-specific third party sources, put together by Global Markets Direct's team.

Scope

* AiCuris GmbH & Co. KG - Brief AiCuris GmbH & Co. KG overview including business description, key information and facts, and its locations

and subsidiaries.
* Review of current pipeline of AiCuris GmbH & Co. KG human therapeutic division.
* Overview of pipeline therapeutics across various therapy areas.
* Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
* Product profiles for late stage and clinical stage products of AiCuris GmbH & Co. KG with complete description of the product's developmental history, mechanism of action, therapeutic class, target and major milestones.
* Recent updates of the AiCuris GmbH & Co. KG's pipeline in the last quarter.
* Key discontinued and dormant projects.
* Latest news and deals relating to the products.


Full Report Details at
- www.fastmr.com/prod/468503_aicuris_gmbh_co_kg_product_pipeline_r ..


Reasons to buy

* Evaluate AiCuris GmbH & Co. KG's strategic position with total access to detailed information on its product pipeline.
* Assess the growth potential of AiCuris GmbH & Co. KG in its therapy areas of focus.
* Identify new drug targets and therapeutic classes in the AiCuris GmbH & Co. KG's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
* Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
* Exploit collaboration and partnership opportunities with AiCuris GmbH & Co. KG.
* Avoid Intellectual Property Rights related issues.
* Explore the dormant and discontinued projects of AiCuris GmbH & Co. KG and identify potential opportunities in those areas.

Partial Table of Contents:

Table of Contents
Table of Contents
List of Tables
List of Figures
AiCuris GmbH & Co. KG Snapshot
AiCuris GmbH & Co. KG Overview
Key Information
Key Facts
AiCuris GmbH & Co. KG - Research and Development Overview
Key Therapeutic Areas
AiCuris GmbH & Co. KG - Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products - Monotherapy
AiCuris GmbH & Co. KG - Pipeline Products Glance
AiCuris GmbH & Co. KG Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
Phase I Products/Combination Treatment Modalities
AiCuris GmbH & Co. KG - Early Stage Pipeline Products
Pre-Clinical Products/Combination Treatment Modalities
Discovery Products/Combination Treatment Modalities
AiCuris GmbH & Co. KG - Drug Profiles
AIC-292
Product Description
Mechanism of Action
R&D Progress
AIC-316
Product Description
Mechanism of Action
R&D Progress
BAC Program
Product Description
Mechanism of Action
R&D Progress
HBV Therapy
Product Description
Mechanism of Action
R&D Progress
HCV-Specific Enzymes Inhibitor
Product Description
Mechanism of Action
R&D Progress
Immune modulator program
Product Description
Mechanism of Action
R&D Progress
letermovir
Product Description
Mechanism of Action
R&D Progress
VIR Program
Product Description
Mechanism of Action
R&D Progress
AiCuris GmbH & Co. KG - Pipeline Analysis
AiCuris GmbH & Co. KG - Pipeline Products by Therapeutic Class
AiCuris GmbH & Co. KG - Pipeline Products by Route of Administration
AiCuris GmbH & Co. KG - Pipeline Products By Mechanism of Action
AiCuris GmbH & Co. KG - Recent Pipeline Updates
AiCuris GmbH & Co. KG - Locations And Subsidiaries
Head Office
AiCuris GmbH & Co. KG, Recent Developments
AiCuris GmbH & Co. KG- Press Release
Aug 07, 2012: AiCuris Announces Presentation On AIC246 At International Herpesvirus Workshop
Aug 07, 2012: AiCuris To Present Data On AIC316 At International Herpesvirus Workshop
Apr 16, 2012: AiCuris To Report AIC316 Phase II trial Data At International Meetings
Apr 02, 2012: AiCuris To Present Positive Phase IIb Results Of Letermovir At International Conferences
Feb 14, 2012: AiCuris's Letermovir Meets Primary Efficacy Endpoints In Phase II Trial For Human Cytomegalovirus Prophylaxis In Human Blood Precursor Cell Recipients
Jan 05, 2012: AiCuris Receives Orphan Drug Designation For Letermovir From FDA
Nov 06, 2009: AiCuris Successfully Completes Phase I Trials For AIC316
Financial Deals Landscape
AiCuris GmbH & Co. KG, Deals Summary
AiCuris GmbH & Co. KG, Pharmaceuticals & Healthcare, Deal Details
Venture Financing
AiCuris Raises $75 Million In Second Round Of Venture Financing
Partnerships
4SC Enters Into Co-Development Agreement With AiCuris
Acquisition
Santo Holding Acquires Majority Stake In AiCuris
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

List of Tables
AiCuris GmbH & Co. KG, Key Information
AiCuris GmbH & Co. KG, Key Facts
AiCuris GmbH & Co. KG - Pipeline by Indication, 2012

Full Table of Contents is available at:
-- www.fastmr.com/catalog/product.aspx?productid=468503&dt=t

About Global Markets Direct

Global Markets Direct is a leading provider of global business intelligence and market analysis. It publishes a range of high quality company and market reports created by its large research and analysis capability and drawing from its extensive unique databases of industry-specific information. View more research from Global Markets Direct at www.fastmr.com/catalog/publishers.aspx?pubid=1033

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at www.fastmr.com or call us at 1.800.844.8156.